Stock Price Quote

HIKAL LTD.

NSE : HIKALBSE : 524735ISIN CODE : INE475B01022Industry : Pharmaceuticals & DrugsHouse : Kalyani
BSE126.302.25 (+1.81 %)
PREV CLOSE ( ) 124.05
OPEN PRICE ( ) 123.10
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 44968
TODAY'S LOW / HIGH ( )122.00 127.45
52 WK LOW / HIGH ( )100.75 187.15
NSE126.102.25 (+1.82 %)
PREV CLOSE( ) 123.85
OPEN PRICE ( ) 123.45
BID PRICE (QTY) 126.10 (746)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 256073
TODAY'S LOW / HIGH( ) 121.85 127.50
52 WK LOW / HIGH ( )100.3 187.7
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1988
Management Info
Jai Hiremath - Chairman Jai Hiremath - Managing Director
Registered Office

Address 717 / 718,Maker Chambers V,Nariman Point,
Mumbai,
Maharashtra-400021

Phone 66301801 / 22834587

Email info@hikal.com

Website www.hikal.com

Registrars Details
Universal Capital Securities Pvt. Ltd
(Formerly Mondkar Computers Pvt Ltd), 21 Shakil Niwas ,Opp. Satya Saibaba Temple, Mahakali Caves Road,Andheri (E),Mumbai
Listing : BSE, NSE, MCX

NEWS

05Feb Board declares Interim Dividend
Hikal Ltd has informed BSE that the Board of Directors of the Company at..
27Jan Hikal informs about trading window clo
Hikal has informed thattrading window closure will commence from January..
13Dec Biocon, Infosys and Sambhaav Media to
Biocon and Equillium Inc. have expanded their collaboration and license..
12Dec Hikal gets EIR for pharmaceutical faci
Hikal has received the Establishment Inspection Report (EIR) from the US..
04Nov Hikal gets EIR from USFDA for API unit
Hikal has received the Establishment Inspection Report (EIR) from the US..

Financials

in Millions
QTR Dec 19 ANNUAL 19
Net Profit283.61030.7
Gross Profit 423.4 1490.8
Operating Profit 761.23003.9
Net Sales 4040.615896.1

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Sanofi India (BSE)
peergroup  7322.90 (2.05%)
M.Cap ( in Cr)16865.09
Ajanta Pharma (BSE)
peergroup  1446.05 (10.03%)
M.Cap ( in Cr)12618.42
Ipca Laboratories (BSE)
peergroup  1456.15 (3.43%)
M.Cap ( in Cr)18398.76
Solara Active Pharma (BSE)
peergroup  680.25 (6.01%)
M.Cap ( in Cr)1772.41
Alkem Laboratories (BSE)
peergroup  2657.75 (1.39%)
M.Cap ( in Cr)31777.39

Shareholding Pattern

PROMOTERS 68.77%
NON-INSTITUTION 24.43%
MUTUAL FUNDS/UTI 2.02%
FI/BANKS/INSURANCE 0.24%
GOVERNMENT 0%
FII 0%

About Hikal Ltd.

Hikal Ltd. was incorporated in the year 1988. Its today's share price is 126.3. Its current market capitalisation stands at Rs 1557.29 Cr. In the latest quarter, company has reported Gross Sales of Rs. 15896.09 Cr and Total Income of Rs.15918.73 Cr. The company's management includes Shivani Bhasin Sachdeva, Sugandha Hiremath, Ranjit Shahani, Amit Kalyani, Kannan Unni, Shivkumar Kheny, Prakash Mehta, Baba Kalyani, Sameer Hiremath, Jai Hiremath, Jai Hiremath.

It is listed on the BSE with a BSE Code of 524735 , NSE with an NSE Symbol of HIKAL and ISIN of INE475B01022. It's Registered office is at 717 / 718,Maker Chambers V,Nariman PointMumbai-400021, Maharashtra. Their Registrars are ACC Ltd. It's auditors are BSR & Co, BSR & Co LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X